Insider Transactions in Q2 2025 at Royalty Pharma PLC (RPRX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2025
|
Legorreta Pablo G. CEO, Chairman of the Board |
BUY
Other acquisition or disposition
|
Direct |
530,348
+37.54%
|
-
|
|
May 13
2025
|
Catherine M. Engelbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+12.96%
|
-
|
|
May 13
2025
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+18.6%
|
-
|
|
May 13
2025
|
Ted W Love Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+12.39%
|
-
|
|
May 13
2025
|
Gregory Norden Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+8.34%
|
-
|
|
May 13
2025
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+9.8%
|
-
|
|
May 13
2025
|
Vlad Coric Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+41.35%
|
-
|
|
May 13
2025
|
Errol B Desouza Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+8.56%
|
-
|
|
May 13
2025
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+10.59%
|
-
|
|
May 08
2025
|
George W. Lloyd EVP, Investments & CLO |
BUY
Grant, award, or other acquisition
|
Indirect |
48,646
+50.0%
|
-
|
|
May 08
2025
|
Legorreta Pablo G. CEO, Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
288,352
+45.02%
|
-
|
|
May 08
2025
|
Terrance P. Coyne EVP & CFO |
BUY
Grant, award, or other acquisition
|
Indirect |
48,646
+50.0%
|
-
|
|
May 08
2025
|
Christopher Hite EVP & Vice Chairman |
BUY
Grant, award, or other acquisition
|
Indirect |
48,646
+6.98%
|
-
|
|
May 08
2025
|
Marshall Urist EVP, Research & Investments |
BUY
Grant, award, or other acquisition
|
Direct |
36,484
+30.5%
|
-
|
|
Apr 21
2025
|
Vlad Coric Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,184
+50.0%
|
-
|